Dr. Meng is a Principle Investigator of the Brain Cognition and Brain Disease Institute of Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Group Leader of Shenzhen Neher Laboratory of Neural Plasticity, Vice director of Shenzhen Key Laboratory of Drug Addiction. He was honored as Shenzhen Talent Program (Peacock Program). As part of the non-human primate research platform of Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences and the Major Infrastructure of Shenzhen Brain Analysis and Brain Simulation, Dr. Meng's research utilizes non-human primate models, combined with behavioral, pharmacological, electrophysiological, magnetic resonance imaging and non-invasive neuromodulation technology, etc., to study the brain mechanism of neuropsychiatric diseases. The aim is to develop new therapeutic or intervention strategies. Currently, the laboratory has animal models such as drug addiction, depression, sleep disorders, PD, etc. 

2019.1-               Investigator           BCBDI-Shenzhen Institutes of Advanced Technology, CAS

2017.3-2019.1    Postdoc                 Brandeis University

2013.8-2017.2    Instructor               University of Mississippi Medical Center

2010.8-2013.8    Research Fellow   Harvard Medical School

2003.9-2010.3    Ph.D.                     Kunming Institute of Zoology, CAS

1999.9-2003.6    B.S.                       Hebei Normal University

Fundings and supports：

1. 药物成瘾核心临床特征的微环路机制及先导化合物，科技创新2030-“脑科学与类脑研究”重大项目：药物成瘾发病机制及干预技术研究，2021-2026，项目骨干

2. 前额叶在多任务整合中的神经环路机制，国自然区域创新发展联合基金重点项目，2021-2024，项目骨干

3. 重要精神疾病发生与干预的神经生物学共性机制研究， 国自然区域创新发展联合基金集成项目， 2021-2024， 项目骨干

4. 无创神经调控干预成瘾渴求的神经机制研究，广东省面上项目，2025-2027，主持

5. 帕金森病新型靶向多肽药物研发，深圳市孔雀团队，2022-2027，项目骨干

6. 非人灵长类药物成瘾与认知功能研究，深圳市药物成瘾重点实验室项目，2020-2022，项目骨干

7. tACS与tDCS（经颅电刺激）对阿尔兹海默病进程的干预及机制研究，国自然地区联合基金，2018-2021， 项目骨干 

8. 经颅超声刺激对抑郁样行为的干预作用，企业合作项目，2021-2024，主持